IP Library Granted Patent US 8,409,803
Granted Patent B2
US 8,409,803 · App. 12/529,577 · Granted Apr 2, 2013

Respiratory syncytial virus (RSV) viral load detection assay

Inventors: David Nauwelaers (Kortrijk-Dutsel, BE); Lieven Jozef Stuyver (Herzele, BE); Alison Velyian Todd (Glebe, AU); Elisa Mokany (Woolooware, AU); Paul Ean Young (Engadine, AU)
Assignee: SpeeDX Pty Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,409,803
App. No.
12/529,577
Granted
Apr 2, 2013
Kind
B2
Abstract

The invention concerns a method for the extraction of nucleic acids from biological samples e.g. tissue material or sputum derived from human or animal species and the quantitative detection thereafter of said nucleic acids e.g. in terms of viral load, more specifically RSV viral load detection.

Claims (10)

1. A method for identifying, detecting or quantifying the presence of at least one target Respiratory Syncytial Virus (RSV) nucleic acid in a sample, comprising the following steps:

(a) providing two or more oligonucleotide components having the ability to anneal to the target RSV nucleic acid, wherein a first oligonucleotide component and a second oligonucleotide component are capable of forming a catalytically active multi-component nucleic acid enzyme (MNAzyme) once annealed to the target RSV nucleic acid;

(b) contacting said two or more oligonucleotide components with said sample wherein said sample permits the binding of said at least one target RSV nucleic acid to said two or more oligonucleotide components and formation of the MNAzyme;

(c) contacting the MNAzyme with a catalyzable nucleic acid reporter substrate that is separate from the at least one target RSV nucleic acid; and

(d) identifying, detecting or quantifying the presence of the target RSV nucleic acid by detecting catalysis of the nucleic acid reporter substrate.

2. The method according to claim 1 , wherein the viral load of RSV in said sample is determined by quantifying the catalytic products produced by the MNAzyme.

3. The method of claim 1 , wherein the catalytic activity of the MNAzyme comprises cleavage of a nucleic acid reporter substrate.

4. The method of claim 3 , wherein the nucleic acid reporter substrate is labeled.

5. The method of claim 4 , wherein detection of the label is enhanced following cleavage of the nucleic acid reporter substrate.

6. The method of claim 4 , wherein the label is a fluorophore.

Assignments (6)
CIVIL PARTNERSHIP WITH LEGAL FORM OF CVBA Recorded Feb 1, 2013
From: VIRCO BVBA
To: TIBOTEC-VIRCO VIROLOGY
Reel/Frame 029733/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: JANSSEN DIAGNOSTICS BVBA (FORMERLY VIRCO BVBA)
To: SPEEDX PTY LTD.
Reel/Frame 029737/0103 →
CHANGE OF NAME Recorded Feb 1, 2013
From: TIBOTEC-VIRCO VIROLOGY
To: JANSSEN INFECTIOUS DISEASES-DIAGNOSTICS [AKA JANSSEN DIAGNOSTICS BVBA]
Reel/Frame 029737/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2012
From: JOHNSON & JOHNSON RESEARCH PTY LIMITED
To: SPEEDX PTY LTD.
Reel/Frame 028020/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2012
From: NAUWELAERS, DAVID; STUYVER, LIEVEN JOZEF
To: VIRCO BVBA
Reel/Frame 027664/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2012
From: TODD, ALISON VELYIAN; MOKANY, ELISA; YOUNG, PAUL EAN
To: JOHNSON & JOHNSON RESEARCH PTY LIMITED
Reel/Frame 027664/0934 →
Priority Claims (2)
EP 07105823 · Apr 6, 2007 · regional
EP 07108211 · May 15, 2007 · regional
Continuity (1)
Related Publication 20100221711A1 · Sep 2, 2010